What it is (overview)

A CT Guided Soft Tissue Biopsy is a minimally invasive diagnostic test in which a doctor uses a CT scan (computed tomography) to guide a needle into a specific area of soft tissue—such as muscle, fat, lymph nodes, or an organ—to remove a small tissue sample. The sample is then examined in a laboratory by a pathologist under a microscope, and may also be tested for infection, inflammation, or genetic changes. CT guidance provides detailed medical imaging so the needle can be placed accurately, especially when the area is deep inside the body or close to important structures.

This test does not “measure” a number like a blood test. Instead, it provides a tissue diagnosis. Results typically fall into categories such as:

Benign (non-cancerous): The tissue shows no cancer. It may show normal tissue, a harmless growth, scarring, or a non-cancerous tumor.

Malignant (cancerous): The tissue shows cancer. The report may identify the cancer type (for example, carcinoma, sarcoma, lymphoma, or metastatic disease) and may include details that help plan treatment.

Infection or inflammation: The tissue may show an abscess, granulomatous inflammation, autoimmune-related inflammation, or organisms (bacteria, fungi, or tuberculosis). Cultures may be ordered to identify the germ and best antibiotic.

Non-diagnostic/insufficient sample: Occasionally, the sample is too small or doesn’t capture the right area. In that case, your clinician may recommend repeating the biopsy, using a different imaging method, or considering a surgical biopsy.

When & why it's usually done

Doctors commonly order a CT guided soft tissue biopsy when imaging (such as a CT scan, MRI, ultrasound, or PET scan) shows a mass, nodule, thickening, or abnormal soft tissue that needs a definite diagnosis. Because imaging alone cannot always confirm whether something is cancer, infection, or inflammation, a biopsy is often the most reliable way to determine the cause and guide next steps.

This diagnostic test may be recommended if you have:

Concerning imaging findings—for example, a new or enlarging soft tissue mass, an unexplained lesion in an organ, or suspicious lymph nodes.

Symptoms that suggest a tumor or serious condition, such as an unexplained lump, persistent or worsening pain, swelling, unexplained weight loss, fevers or night sweats, fatigue, or reduced appetite.

Possible cancer detection or staging needs—to confirm a suspected cancer, determine whether a cancer has spread (metastasis), or identify the exact tumor type so treatment can be chosen appropriately.

Concern for infection—such as a suspected abscess or deep infection when blood tests and imaging are not enough, or when the specific organism needs to be identified for targeted therapy.

Inflammatory or autoimmune concerns—when conditions like inflammatory masses or granulomatous disease are being considered and tissue confirmation is needed.

CT guidance is often chosen when the target area is deep (for example, in the chest, abdomen, pelvis, or retroperitoneum), not clearly visible on ultrasound, or requires very precise needle placement to reduce risk and improve accuracy.

Common diseases related to it

• Soft tissue sarcoma (cancer arising from muscle, fat, or connective tissue)
• Metastatic cancer to soft tissues or organs (spread from another primary cancer)
• Lymphoma involving lymph nodes or extranodal soft tissue
• Benign soft tissue tumors (e.g., lipoma, benign fibrous tumors)
• Abscess or deep soft tissue infection
• Tuberculosis or atypical mycobacterial infection
• Fungal infections (in deeper tissues or organs)
• Granulomatous inflammation (e.g., sarcoidosis or related conditions)
• Inflammatory or autoimmune-related masses (depending on location and clinical context)
• Organ lesions requiring biopsy (organ biopsy), such as suspicious liver, kidney, adrenal, lung, or pelvic soft tissue lesions

Health goals where it may help

• Achieving an accurate diagnosis of a soft tissue mass using CT scan guidance
• Supporting early cancer detection and confirming whether a lesion is benign or malignant
• Identifying the tumor type to guide personalized treatment planning (surgery, chemotherapy, radiation, targeted therapy)
• Determining whether cancer has spread (staging) to inform prognosis and next steps
• Clarifying unexplained symptoms (persistent pain, swelling, fevers, weight loss) when imaging shows an abnormality
• Diagnosing infection and helping choose the most effective antibiotic or antifungal therapy
• Avoiding unnecessary surgery by using a minimally invasive biopsy to obtain a tissue sample
• Monitoring known or treated disease by confirming recurrence or changes seen on follow-up medical imaging